Working... Menu

Belimumab in Idiopathic Inflammatory Myositis (BIM)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT02347891
Recruitment Status : Recruiting
First Posted : January 28, 2015
Last Update Posted : August 23, 2018
Information provided by (Responsible Party):
Galina Marder, MD, Northwell Health

No Study Results Posted on for this Study
  Recruitment Status : Recruiting
  Estimated Primary Completion Date : December 2019
  Estimated Study Completion Date : December 2019